ASP Isotopes Inc. (NASDAQ:ASPI) Short Interest Update

ASP Isotopes Inc. (NASDAQ:ASPIGet Free Report) was the target of a large drop in short interest in November. As of November 15th, there was short interest totalling 5,570,000 shares, a drop of 48.4% from the October 31st total of 10,800,000 shares. Based on an average daily volume of 4,050,000 shares, the short-interest ratio is currently 1.4 days. Approximately 12.3% of the company’s stock are short sold.

Hedge Funds Weigh In On ASP Isotopes

Several large investors have recently added to or reduced their stakes in ASPI. Telemark Asset Management LLC acquired a new stake in shares of ASP Isotopes during the third quarter worth $4,726,000. Fiera Capital Corp bought a new stake in shares of ASP Isotopes during the 3rd quarter valued at about $723,000. GSA Capital Partners LLP raised its stake in ASP Isotopes by 96.0% during the third quarter. GSA Capital Partners LLP now owns 770,989 shares of the company’s stock worth $2,143,000 after acquiring an additional 377,721 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. bought a new position in ASP Isotopes in the third quarter worth about $6,249,000. Finally, Marshall Wace LLP boosted its stake in ASP Isotopes by 389.6% in the second quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock valued at $1,668,000 after acquiring an additional 433,734 shares during the period. 16.80% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on ASPI shares. Canaccord Genuity Group reiterated a “buy” rating and issued a $4.50 price target on shares of ASP Isotopes in a research note on Friday, October 18th. HC Wainwright reduced their target price on ASP Isotopes from $5.50 to $4.50 and set a “buy” rating for the company in a research note on Wednesday, August 7th. Finally, Canaccord Genuity Group assumed coverage on shares of ASP Isotopes in a research note on Friday, October 4th. They set a “buy” rating and a $4.50 price objective on the stock.

Read Our Latest Report on ASP Isotopes

ASP Isotopes Stock Up 10.6 %

NASDAQ ASPI traded up $0.53 on Friday, hitting $5.55. 3,833,717 shares of the stock traded hands, compared to its average volume of 1,796,681. The company has a market capitalization of $396.21 million, a P/E ratio of -9.10 and a beta of 3.88. The stock has a 50-day moving average of $5.26 and a 200 day moving average of $3.93. The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80. ASP Isotopes has a twelve month low of $1.65 and a twelve month high of $9.33.

About ASP Isotopes

(Get Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

Featured Articles

Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.